1. Home
  2. SHIP vs SABS Comparison

SHIP vs SABS Comparison

Compare SHIP & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seanergy Maritime Holdings Corp.

SHIP

Seanergy Maritime Holdings Corp.

HOLD

Current Price

$9.60

Market Cap

199.1M

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$4.00

Market Cap

187.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIP
SABS
Founded
2008
2014
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.1M
187.6M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
SHIP
SABS
Price
$9.60
$4.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$11.00
$9.80
AVG Volume (30 Days)
133.5K
344.6K
Earning Date
03-05-2026
11-13-2025
Dividend Yield
7.70%
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$150,354,000.00
$114,698.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.68
N/A
P/E Ratio
$13.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.78
$1.00
52 Week High
$11.15
$6.60

Technical Indicators

Market Signals
Indicator
SHIP
SABS
Relative Strength Index (RSI) 52.32 58.45
Support Level $9.32 $3.82
Resistance Level $9.50 $4.21
Average True Range (ATR) 0.29 0.27
MACD 0.04 0.02
Stochastic Oscillator 68.54 74.84

Price Performance

Historical Comparison
SHIP
SABS

About SHIP Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: